Caracterización demográfica y clínica de pacientes críticos con neumonía por influenza A H1N1

Palabras clave: Neumonía, Neumonía VIral, Subtipo N1H1 del Virus del la Influenza A, Sepsis, Síndrome de Dificultad Respiratoria del Adulto, Infecciones Coomunitarias Adquiridas

Resumen

INTRODUCCIÓN. La epidemia de influenza y sus complicaciones profundizaron el estudio de las neumonías virales en cuidados intensivos. En nuestro país hay pocos datos sobre este tema. OBJETIVOS. Realizar una caracterización demográfica y clínica de pacientes críticos con neumonía por Influenza A H1N1 en un hospital de tercer nivel de complejidad. MATERIALES Y MÉTODOS. Estudio observacional, analítico, retrospectivo, con análisis univariante y multivariante. Población de 293 y
muestra de 44 datos de historias clínicas electrónicas de pacientes diagnosticados con A H1N1 ingresados a la Unidad de cuidados intensivos del Hospital de Especialidades Carlos Andrade Marín en el período enero 2016 a diciembre de 2018. Como criterios de inclusión se consideró a todos los pacientes adultos mayores de 18 años que ingresaron a la UCI, con el diagnóstico de neumonía comunitaria grave con confirmación por reacción de cadena de polimerasa en tiempo real para influenza A H1N1 en hisopado nasal o aspirado traqueal. Se excluyó a pacientes embarazadas
con diagnóstico de influenza A H1N1, pacientes con más de 48 horas de ingreso hospitalario previo a su ingreso a UCI, pacientes con datos insuficientes en los registros. Los datos se obtuvieron del sistema AS-400. El análisis estadístico se realizó en el programa Statistical Package for Social Sciences, versión 22. El nivel de significación fue una p<0.05. RESULTADOS. La prevalencia en pacientes críticos de neumonía por influenza A H1N1 durante 2016-2018 fue de 16,72%, la mediana de edad fue de
55 años, 25% masculinos, 34% obesos, 34% con hipertensión arterial. Escala “Acute Physiology and Chronic Health Evaluation II” 23,50, “Simplified Acute Physiologic Score III” 54, “Sepsis related Organ Failure Assessment” 11,50, Lactato deshidrogenasa 99,50, Procalcitonina 0,99; 9 días de ventilación mecánica invasiva, 10,50 días de estancia en la unidad. El 91% presentó shock séptico, 59% lesión renal aguda. El 89% tuvo Síndrome de Distrés Respiratorio del Adultos, 69% fue grave, 87% usó
ventilación mecánica, 38,50% corticoides, 36% posición prona, Presión parcial de oxígeno/Fracción inspirada de oxígeno 74, volumen tidal/kilogramo de 7 mililitros, presión plateau de 27,50 centímetros de agua. La mortalidad general en la Unidad de Cuidados Intensivos fue de 38,63% y a los 28 días de 63,60%, en shock séptico fue 42,50% y en Síndrome de Distrés Respiratorio del Adultos del 41,02%. El análisis de regresión logística multivariable identificó como factores independientes asociados a
mortalidad el incremento de Lactato deshidrogenasa (OR 2,69, 9% IC 1,090-6,642) y Procalcitonina (OR 2,51, IC 1,005-6,272). CONCLUSIONES. Las características, frecuencia y mortalidad de este grupo de pacientes críticos con neumonía por influenza A H1N1 son similares a lo reportado en la literatura mundial.

Descargas

La descarga de datos todavía no está disponible.

Citas

Daoud A, Laktineh A, Macrander C, Mushtaq A, Soubani AO. Pulmonary complications of influenza infection: a targeted narrative review. Postgrad Med [Internet]. 2019 Jul 4 [cited 2021 May 13];131(5):299–308.

DOI: 10.1080/00325481.2019.1592400.

Peteranderl C, Herold S, Schmoldt C. Human influenza virus infections. In: Seminars in respiratory and critical care medicine. Thieme Medical Publishers; 2016. p. 487–500.

DOI: 10.1055/s-0036-1584801.

Beumer MC, Koch RM, Van Beuningen D, OudeLashof AM, Van de Veerdonk FL, Kolwijck E, et al. Influenza

virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality. J Crit Care. 2019;50:59–65.

DOI: 10.1016/j.jcrc.2018.11.013.

Lin GL, McGinley JP, Drysdale SB, Pollard AJ. Epidemiology and immune pathogenesis of viral sepsis.

Front Immunol. 2018; 9:2147. Disponible en:

https://doi.org/10.3389/fimmu.2018.02147.

Abelleira R, Ruano-Ravina A, Lama A, Barbeito G, Toubes ME, Dominguez-Antelo C, et al. Influenza A H1N1 community-acquired pneumonia: characteristics and risk factors—a case-control study. Can Respir J. 2019;2019. Disponible en:

https://doi.org/10.1155/2019/4301039.

Chow EJ, Doyle JD, Uyeki TM. Influenza virus-related critical illness: prevention, diagnosis, treatment. Crit Care. 2019;23(1):1–11. Disponible en:

https://doi.org/10.1186/s13054-019-2491-9.

Cantan B, Luyt CE, Martin-Loeches I. Influenza infections and emergent viral infections in intensive care unit. In: Seminars in respiratory and critical care medicine. Thieme Medical Publishers; 2019. p. 488–97.

DOI: 10.1055/s-0039-1693497.

Wunderink RG, Waterer G. Advances in the causes and management of community acquired pneumonia in adults. BMJ. 2017;358:j2471.

DOI: https://doi.org/10.1136/bmj.j2471.

Athlin S, Lidman C, Lundqvist A, Naucler P, Nilsson AC, Spindler C, et al. Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017. Infect Dis [Internet]. 2018 Apr 3 [cited 2020 Dec 30];50(4):247–72. Available from:

https://www.tandfonline.com/doi/full/10.1080/23744235.2017.1399316.

Garnacho-Montero J, Barrero-García I, Gómez-Prieto M de G, Martín-Loeches I. Severe community-acquired pneumonia: current management and future therapeutic alternatives. Expert Rev Anti Infect Ther [Internet]. 2018 Sep 2 [cited 2020 Oct 6];16(9):667–77. Available from:

https://www.tandfonline.com/doi/full/10.1080/14787210.2018.1512403.

Montull B, Menéndez R, Torres A, Reyes S, Méndez R, Zalacaín R, et al. Predictors of Severe Sepsis among Patients Hospitalized for Community-Acquired Pneumonia. Yende S, editor. PLOS ONE [Internet]. 2016 Jan 4 [cited 2021 May 13];11(1):e0145929.

Available from: https://dx.plos.org/10.1371/journal.pone.0145929.

Cilloniz C, Ferrer M, Liapikou A, Garcia-Vidal C, Gabarrus A, Ceccato A, et al. Acute respiratory distress syndrome in mechanically ventilated patients with community-acquired pneumonia. Eur Respir J [Internet]. 2018 Mar [cited 2021 May 13];51(3):1702215. Available from:

http://erj.ersjournals.com/lookup/doi/10.1183/13993003.02215-2017.

CDC. Visión general de los métodos de pruebas de detección de la influenza | CDC [Internet]. 2020 [cited 2020 Oct 6]. Available from:

https://espanol.cdc.gov/flu/professionals/diagnosis/overview-testing-methods.htm.

CDC. Información sobre pruebas moleculares rápidas, RT-PCR y otras pruebas moleculares para el diagnóstico de infección por el virus de la influenza | CDC [Internet]. 2019 [cited 2020 Oct 6]. Available from: https://espanol.cdc.gov/flu/professionals/diagnosis/molecular-assays.htm.

Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis. 2000;31(2):347–82. DOI: https://doi.org/10.1086/313954.

Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163(7):1730–54.

DOI: https://doi.org/10.1164/ajrccm.163.7.at1010.

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). Jama. 2016;315(8):801–10.

DOI: 10.1001/jama.2016.0287.

Force ADT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson N, Caldwell E, et al. Acute respiratory distress syndrome. Jama. 2012;307(23):2526–33.

DOI: 10.1001/jama.2012.5669.

Arabi YM, Fowler R, Hayden FG. Critical care management of adults with community-acquired severe respiratory viral infection. Intensive Care Med [Internet]. 2020 Feb [cited 2022 Sep 5];46(2):315–28. Available from:

http://link.springer.com/10.1007/s00134-020-05943-5.

Tatarelli P, Magnasco L, Borghesi ML, Russo C, Marra A, Mirabella M, et al. Prevalence and clinical impact

of VIral Respiratory tract infections in patients hospitalized for Community-Acquired Pneumonia: the VIRCAP study. Intern Emerg Med [Internet]. 2020 Jun [cited 2022 Sep 5];15(4):645–54. Available from: http://link.springer. com/10.1007/s11739-019-02243-9.

Rodríguez A, Alvarez-Rocha L, Sirvent JM, Zaragoza R, Nieto M, Arenzana A, et al. Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit. Med Intensiva Engl Ed. 2012;36(2):103–37.

DOI: https://doi.org/10.1016/j.medin.2011.11.020.

Douce RW, Aleman W, Chicaiza-Ayala W, Madrid C, Sovero M, Delgado F, et al. Sentinel surveillance of influenza-like-illness in two cities of the tropical country of Ecuador: 2006–2010. PLoS One. 2011;6(8):e22206.

DOI: https://doi.org/10.1371/journal.pone.0022206.

MSP. Actualización Epidemiológica – Influenza – Ministerio de Salud Pública [Internet]. [cited 2022 Nov 22]. Available from:

https://www.salud.gob.ec/actualizacion-epidemiologica-influenza/

Fernández-Serrano S, Dorca J, Garcia-Vidal C, Fernández-Sabé N, Carratalà J, Fernández-Agüera A, et al. Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial. Crit Care. 2011;15(2):R96.

DOI: https://doi.org/10.1186/cc10103.

Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(Suppl 3):iii1–55. DOI: https://doi.org/10.1136/thx.2009.121434.

Hernández G, Ospina-Tascón GA, Damiani LP, Estenssoro E, Dubin A, Hurtado J, et al. Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical

Trial. JAMA [Internet]. 2019 Feb 19 [cited 2021 Jul 20];321(7):654. Available from:

http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2019.0071

Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA [Internet]. 2016 Feb 23 [cited 2021 Jul 20];315(8):788. Available from:

http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.0291.

Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. The Lancet. 2018;391(10127):1285–300.

DOI: 10.1016/S0140-6736(17)33293-2.

Oliva J, Delgado-Sanz C, Larrauri A, System SIS, Gallardo V, Navarro JM, et al. Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010-2016. Influenza Other Respir Viruses. 2018;12(1):161–70.

DOI: https://doi.org/10.1111/irv.12499.

Hong WC, Sun SF, Hsu CW, Lee DL, Lee CH. Clinical Characteristics and Predictors of Mortality in Critically

Ill Adult Patients with Influenza Infection. Int J Environ Res Public Health [Internet]. 2021 Apr 1 [cited 2021

Jul 15];18(7):3682. Available from:

https://www.mdpi.com/1660-4601/18/7/3682.

Moreno G, Rodríguez A, Reyes LF, Gomez J, Sole-Violan J, Díaz E, et al. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study. Intensive Care Med. 2018;44(9):1470–82.

DOI: https://doi.org/10.1007/s00134-018-5332-4.

Garnacho-Montero J, León-Moya C, Gutiérrez-Pizarraya A, Arenzana-Seisdedos A, Vidaur L, Guerrero JE,

et al. Clinical characteristics, evolution, and treatment-related risk factors for mortality among immunosuppressed patients with influenza A (H1N1) virus admitted to the intensive care unit. J Crit Care [Internet]. 2018 Dec [cited 2021 Jul 20];48:172–7.

DOI: https://doi.org/10.1016/j.jcrc.2018.08.017.

Rello J, Rodríguez A, Ibañez P, Socias L, Cebrian J, Marques A, et al. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1) v in Spain. Crit Care. 2009;13(5):1–9. DOI: https://doi.org/10.1186/cc8044.

Marin-Corral J, Climent C, Muñoz R, Samper M, Dot I, Vilà C, et al. Patients with influenza A (H1N1) pdm09 admitted to the ICU. Impact of the recommendations of the SEMICYUC. Med Intensiva Engl Ed. 2018;42(8):473–81.

DOI: https://doi.org/10.1016/j.medine.2018.08.002.

Domínguez-Cherit G. Critically Ill Patients With 2009 Influenza A(H1N1) in Mexico. JAMA [Internet]. 2009

Nov 4 [cited 2022 Aug 26];302(17):1880. Available from:

http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2009.1536.

Rodríguez A, Socias L, Guerrero JE, Figueira JC, González N, Maravi-Poma E, et al. Pandemic influenza A in the ICU: experience in Spain and Latin America. GETGAG/SEMICYUC/(Spanish Working Group on Severe Pandemic Influenza A/SEMICYUC). Med Intensiva. 2010;34(2):87–94.

DOI: https://doi.org/10.1016/j.medin.2009.12.005.

Raffo L. Influenza A (H1N1) epidemic in Argentina. Experience in a national general hospital (Hospital Nacional Alejandro Posadas). Medicina (Mex). 2009;69(4):393–423. Availabe from: https://pubmed.ncbi.nlm.nih.gov/19770095/.

Censos IN de E y. Defunciones Generales 2019 [Internet]. Instituto Nacional de Estadística y Censos. [cited 2021 May 14]. Available from:

https://www.ecuadorencifras.gob.ec/

defunciones-generales-2019/.

Gu X, Zhou F, Wang Y, Fan G, Cao B. Respiratory viral sepsis: epidemiology, pathophysiology, diagnosis and treatment. Eur Respir Rev [Internet]. 2020 Sep 30 [cited 2022 Aug 17];29(157):200038. Available from: http://err.ersjournals.com/lookup/doi/10.1183/16000617.0038-2020.

Banda-Lara MI, Hidalgo-Loperena H, Rivera-Benitez C. Severidad de la neumonía asociada a influenza A H1N1: Evaluación de escalas de severidad. Rev Med Hosp Gen Mex. 2011;74:1–2. Disponible en: https://www.imbiomed.com.mx/articulo.php?id=71800.

Cillóniz C, Ewig S, Menéndez R, Ferrer M, Polverino E, Reyes S, et al. Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia. J Infect. 2012;65(3):223–30. DOI: https://doi.org/10.1016%2Fj.jinf.2012.04.009.

Morejón Jaramillo PE. Factores asociados con mortalidad en pacientes confirmados con influenza A (H1N1) en un hospital terciario del Ecuador desde el 26 de noviembre de 2017 hasta el 24 de febrero de 2018 [B.S. thesis]. Quito; 2018.

DOI: http://repositorio.usfq.edu.ec/handle/23000/7665.

Luyt CÉ, Combes A, Trouillet JL, Nieszkowska A, Chastre J. Virus-induced acute respiratory distress syndrome: Epidemiology, management and outcome. Presse Médicale [Internet]. 2011 Dec [cited 2022 Sep 13];40(12):e561–8.

Available from: https://linkinghub.elsevier.com/retrieve/pii/S0755498211004933.

Li H, Weng H, Lan C, Zhang H, Wang X, Pan J, et al. Comparison of patients with avian influenza A (H7N9) and influenza A (H1N1) complicated by acute respiratory distress syndrome. Medicine (Baltimore) [Internet]. 2018 Mar [cited 2022 Sep 13];97(12):e0194. Available from:

https://journals.lww.com/00005792-201803230-00037.

Jamoussi A, Ayed S, Merhabene T, Doghri H, Ben Khelil J, Besbes M. Severe influenza A in a Tunisian ICU sentinel SARI centre: Epidemiological and clinical features. Plos One. 2022;17(7):e0270814.

DOI: https://doi.org/10.1371/journal.pone.0270814.

Jaber S, Conseil M, Coisel Y, Jung B, Chanques G. ARDS and influenza A (H1N1): patients’ characteristics and management in intensive care unit. A literature review. In: Annales francaises d’anesthesie et de reanimation. 2010. p. 117–25. DOI:

https://doi.org/10.1016/j.annfar.2009.12.026.

Haro López C de, Ferrer Roca R, Vallés Daunis J. Neumonía y síndrome de distrés respiratorio agudo producido por el virus influenza A (H1N1). Med Intensiva. 2009;33(9):455–8.

DOI: 10.1016/j.medin.2009.09.004.

Bouneb R, Mellouli M, Bensoltane H, Baroudi J, Chouchene I, Boussarsar M. Characteristics and outcome of ill critical patients with influenza A infection. Pan Afr Med J. 2018;29(1):1–8.

DOI: 10.11604/pamj.2018.29.174.13098.eCollection 2018.

Paredes G, Cevallos C. Síndrome de Distrés Respiratorio Agudo, durante la pandemia de Influenza A H1N1 2009 en Ecuador. Med Intensiva [Internet]. 2010 Jun [cited 2021 Aug 4];34(5):310–7. Available from: https://scielo.isciii.es/scielo.php?script=sci_abstract&pid=S0210-56912010000500004.

Álvarez-Lerma F, Marín-Corral J, Vilà C, Masclans JR, Loeches IM, Barbadillo S, et al. Characteristics of patients with hospital-acquired influenza A (H1N1)pdm09 virus admitted to the intensive care unit. J Hosp Infect [Internet]. 2017 Feb [cited 2022 Aug 26];95(2):200–6. Available from:

https://10.1016/j.jhin.2016.12.017.

Guérin C, Beuret P, Constantin JM, Bellani G, Garcia-Olivares P, Roca O, et al. A prospective international observational prevalence study on prone positioning of ARDS patients: the APRONET (ARDS Prone Position Network) study. Intensive Care Med [Internet]. 2018 Jan [cited 2022 Sep 5];44(1):22–37.

DOI: 10.1007/s00134-017-4996-5.

García-Arroyo A, Rosas-Dossetti M, Santoyo-Sánchez A, Salcedo-Roldán M, Ramos-Peñafiel CO. Deshidrogenasa láctica como factor pronóstico en neumonías. Med Interna México. 2017;33(5):563–71. DOI: https://doi.org/10.24245/mim.v33i5.1042.

Salvador JCN, Garduño LMB, Molina HL, Serrano AT, Macías MER, Murrieta FJF. Prognostic predictors of pneumonia mortality, due to influenza A H1N1 infection. Med

Interna México. 2011;27(5):421–8. Available from:

https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=31188.

Abdelaty NM. Risk factors and prognostic criteria in 230 patients with influenza A (H1N1) infection. Egypt J Chest Dis Tuberc [Internet]. 2013 Jan [cited 2022 Sep 22];62(1):1–8. Available from:

https://doi.org/10.1016/j.ejcdt.2013.02.006.

Pfister R, Kochanek M, Leygeber T, Brun-Buisson C, Cuquemelle E, Machado MB, et al. Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis. Crit Care [Internet]. 2014 [cited 2022 Sep 22];18(2):R44. Available from:

http://ccforum.biomedcentral.com/articles/10.1186/cc13760.

Rodríguez AH, Avilés-Jurado FX, Díaz E, Schuetz P, Trefler SI, Solé-Violán J, et al. Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis. J Infect [In[Internet]. 2016 Feb [cited 2022 Sep 22];72(2):143–51.

DOI: 10.1016/j.jinf.2015.11.007.

Wu MH, Lin CC, Huang SL, Shih HM, Wang CC, Lee CC, et al. Can procalcitonin tests aid in identifying bacterial infections associated with influenza pneumonia? A systematic review and meta-analysis: Procalcitonin test for diagnosis of secondary bacterial pneumonia associated with influenza. Influenza Other Respir Viruses [Internet]. 2013 May [cited 2022 Sep 22];7(3):349–55. Available from: https://onlinelibrary.wiley.com/doi/10.1111/j.1750-2659.2012.00386.x

Publicado
2022-12-30
Cómo citar
1.
Guerrero Toapanta F, Herrera Parra Y, Gangotena Coral A, Velasteguí Silva J, Cruz Betancourt C, Vinueza Rivadeneira J, Ramos Tituaña E, López Altamirano J, Godoy Miketta A. Caracterización demográfica y clínica de pacientes críticos con neumonía por influenza A H1N1. CAMbios-HECAM [Internet]. 30dic.2022 [citado 13feb.2025];21(2):e876. Available from: https://revistahcam.iess.gob.ec/index.php/cambios/article/view/876
Sección
Estudio Original: Estudios Observacionales